CFH and metabolic dysfunction-associated steatotic liver disease: Our findings indicate the influence of genetic variations within the CFH/CFHR1/CFHR3 locus on the recognition and binding of OSEs, thereby affecting outcome in diseases associated with oxidative stress and aging such as NAFLD.